Stockscreener 앱 받기
28.42
0.59%
-0.20
전일 마감가:
$28.62
열려 있는:
$28.59
하루 거래량:
201.09K
Relative Volume:
0.24
시가총액:
$11.73B
수익:
$5.64B
순이익/손실:
$305.00M
주가수익비율:
40.72
EPS:
0.698
순현금흐름:
-
1주 성능:
+6.16%
1개월 성능:
+8.13%
6개월 성능:
+11.31%
1년 성능:
+14.81%
1일 변동 폭
$28.27
$28.59
1주일 범위
$26.58
$29.02
52주 변동 폭
$23.69
$31.72
Smith Nephew Plc Adr Stock (SNN) Company Profile
SNN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNN
Smith Nephew Plc Adr
|
28.42 | 11.73B | 5.64B | 305.00M | 0 | 0.698 |
|
ABT
Abbott Laboratories
|
132.57 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.56 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
381.12 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.72 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.49 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Smith Nephew Plc Adr Stock (SNN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-25 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-03-12 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-11-06 | 다운그레이드 | Berenberg | Buy → Hold |
| 2024-11-01 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-07-24 | 개시 | Deutsche Bank | Buy |
| 2024-06-05 | 업그레이드 | UBS | Neutral → Buy |
| 2023-11-28 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2023-11-03 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-10-31 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2023-10-13 | 개시 | Stifel | Hold |
| 2023-08-08 | 업그레이드 | UBS | Sell → Neutral |
| 2023-04-27 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-04-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-12-12 | 개시 | Citigroup | Buy |
| 2022-11-28 | 다운그레이드 | UBS | Neutral → Sell |
| 2022-10-18 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-07-28 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-03-16 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-15 | 개시 | RBC Capital Mkts | Outperform |
| 2022-03-04 | 업그레이드 | Redburn | Sell → Neutral |
| 2021-06-09 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-18 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2020-12-01 | 개시 | Barclays | Overweight |
| 2020-07-29 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-04 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-11-21 | 개시 | Citigroup | Buy |
| 2019-11-12 | 개시 | Bernstein | Outperform |
| 2019-07-23 | 업그레이드 | Berenberg | Hold → Buy |
| 2019-02-08 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2019-01-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2018-12-10 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-11-01 | 재확인 | Canaccord Genuity | Buy |
| 2018-01-25 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-12-11 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2017-10-11 | 개시 | Canaccord Genuity | Buy |
| 2017-02-27 | 다운그레이드 | Goldman | Buy → Neutral |
| 2017-01-19 | 개시 | HSBC Securities | Hold |
| 2016-12-08 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2016-10-06 | 다운그레이드 | Berenberg | Buy → Hold |
| 2016-02-26 | 개시 | Cantor Fitzgerald | Hold |
모두보기
Smith Nephew Plc Adr 주식(SNN)의 최신 뉴스
Smith & Nephew plc ADR [SNN] Investment Appeal on the Rise - knoxdaily.com
TRI (Thomson-Reuters Corp) may reap gains as insiders became active recently - knoxdaily.com
Glaukos Corporation (GKOS) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Smith+Nephew reports solid Q1 2025 growth - Investing.com
AN Stock Sees Surge of Approximately 3.05% in Last Five Days - knoxdaily.com
Smith+Nephew schedules Q1 2025 trading report release - Investing.com
Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights - GlobeNewswire Inc.
UBS cuts Smith & Nephew stock rating to Neutral, sets GBP1.25 target - Investing.com
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
SNN (Smith & Nephew plc ADR) may reap gains as insiders became active recently - Knox Daily
Wound Closure Market Size to Hit USD 26.63 Billion by 2032, Growing at a CAGR of 6.47% - GlobeNewswire Inc.
Goldman Downgrades Riskified Ltd (RSKD) to a Sell from a Neutral - Knox Daily
Smith+Nephew to announce 2024 full year results February 25 - Investing.com
Smith+Nephew appoints new Non-Executive Director - Investing.com
Endoprosthesis Market Size to Surpass USD 60.39 Billion by 2032 at a CAGR of 9.86% - GlobeNewswire Inc.
Weekly Upgrades and Downgrades - InvestorPlace
Smith & Nephew Earnings: Quarterly Sales Suggest China Weakness Into 2025 - Morningstar
Smith & Nephew Sees Challenges in China Market - Morningstar
Smith+Nephew, JointVue partner on ultrasound-based surgical planning for surgical robotics - Mass Device
Smith+Nephew launches new Legion knee system - Mass Device
South Korea Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
The Best Healthcare Stocks to Buy - Morningstar
Smith & Nephew Aligns Director Fees with Shares - TipRanks
China Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
Japan Surgical Navigation Systems Market Size & Outlook, 2030 - Grand View Research
Smith+Nephew launches Total Ankle patient-matched guides - Mass Device
InfuSystem, Smith+Nephew ink wound therapy distro deal - Mass Device
Smith+Nephew wins FDA nod for hip system compatible with Cori surgical robot - Mass Device
Europe First Aid Market Size & Outlook, 2023-2030 - Grand View Research
Smith & Nephew stock gains on Cevian stake (NYSE:SNN) - Seeking Alpha
Smith+Nephew launches pre-op planning tech for surgical robotics - Mass Device
Healthcare Sector - Morningstar
Here’s Why You Should Invest in Smith & Nephew plc (SNN) - Yahoo Finance
Smith+Nephew rolls out new chronic wound treatment tech - Mass Device
Smith+Nephew sales are up 7% as 12-point plan progresses - Mass Device
Smith+Nephew unveils expanded sports medicine portfolio - Mass Device
Study backs Smith+Nephew Regeneten bioinductive rotator cuff implant - Mass Device
Validea Detailed Fundamental AnalysisSNN - Nasdaq
Smith+Nephew launches hip arthroplasty system in India - Mass Device
Smith+Nephew unveils handheld digital tensioning device for robotic knee surgery - Mass Device
Zimmer Biomet Holdings Inc. stock outperforms market on strong trading day - MarketWatch
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Zimmer Biomet Holdings Inc. stock rises Monday, outperforms market - MarketWatch
Zimmer Biomet Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Smith Nephew Plc Adr (SNN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
9.57%
0.08%
자본화:
|
볼륨(24시간):